TeaRx company develops drugs for the prevention and treatment of thrombosis and thromboembolism. Anticoagulants are vital to the prevention and treatment of various diseases associated with the formation of blood clots, as well as during and after most surgical procedures.

The company is developing an innovative drug, TRX1, which belongs to a new anticoagulant class — inhibitors of blood coagulation factor Xa.


Ajax Call Form